Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joshua Katzhendler is active.

Publication


Featured researches published by Joshua Katzhendler.


PLOS Pathogens | 2012

Relacin, a novel antibacterial agent targeting the Stringent Response.

Ezequiel Wexselblatt; Yaara Oppenheimer-Shaanan; Ilana Kaspy; Nir London; Ora Schueler-Furman; Eylon Yavin; Gad Glaser; Joshua Katzhendler; Sigal Ben-Yehuda

Finding bacterial cellular targets for developing novel antibiotics has become a major challenge in fighting resistant pathogenic bacteria. We present a novel compound, Relacin, designed to inhibit (p)ppGpp production by the ubiquitous bacterial enzyme RelA that triggers the Stringent Response. Relacin inhibits RelA in vitro and reduces (p)ppGpp production in vivo. Moreover, Relacin affects entry into stationary phase in Gram positive bacteria, leading to a dramatic reduction in cell viability. When Relacin is added to sporulating Bacillus subtilis cells, it strongly perturbs spore formation regardless of the time of addition. Spore formation is also impeded in the pathogenic bacterium Bacillus anthracis that causes the acute anthrax disease. Finally, the formation of multicellular biofilms is markedly disrupted by Relacin. Thus, we establish that Relacin, a novel ppGpp analogue, interferes with bacterial long term survival strategies, placing it as an attractive new antibacterial agent.


European Journal of Medicinal Chemistry | 1997

Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs

Dan Gibson; I Binyamin; M Haj; Israel Ringel; Avner Ramu; Joshua Katzhendler

Summary A series of complexes PtAm2L [where Am2 = (NH3)2, ethylenediamine(en), 1,2-diaminocyclohexane (DACH) or (NH3)(c-C6H11NH2) and where L is a bidentate 1,1-dicarboxylate ligand tethered to 1-aminoanthraquinone by various spacers] was prepared and screened in vitro against P388 leukemia cells. The free ligands displayed moderate activity and the corresponding platinum complexes were tenfold more active. The nature of the linker chain does not seem to affect the potency of the complexes. The potency depends on the nature of the inert amine ligand [NH3 > DACH > en]. The low aqueous solubility of these complexes prevented any in vivo studies and the preparation of water soluble analogs is currently under way.


European Journal of Medicinal Chemistry | 2013

Design, synthesis and structure–activity relationship of novel Relacin analogs as inhibitors of Rel proteins

Ezequiel Wexselblatt; Ilana Kaspy; Gad Glaser; Joshua Katzhendler; Eylon Yavin

Rel proteins in bacteria synthesize the signal molecules (p)ppGpp that trigger the Stringent Response, responsible for bacterial survival. Inhibiting the activity of such enzymes prevents the Stringent Response, resulting in the inactivation of long-term bacterial survival strategies, leading to bacterial cell death. Herein, we describe a series of deoxyguanosine-based analogs of the Relacin molecule that inhibit in vitro the synthetic activity of Rel proteins from Gram positive and Gram negative bacteria, providing a deeper insight on the SAR for a better understanding of their potential interactions and inhibitory activity. Among the inhibitors evaluated, compound 2d was found to be more effective and potent than our previously reported Relacin.


European Journal of Medicinal Chemistry | 1991

Preparation, characterization and the anticancer activity of a novel series of triaminemonochloroplatinum(II) cations linked to anthraquinone intercalators

Kf Gean; Raphael Ben-Shoshan; Avner Ramu; Israel Ringel; Joshua Katzhendler; Dan Gibson

Abstract A new series of complexes of the type [PtAm2LCl]+ (where Am = NH3 or Am2 = ethylenediamine and L is a monodentate AQ-Y-(CH2)n-NH2, AQ = anthraquinone, Y = NH, O) was prepared and screened in vitro against P388 leukemia. These complexes displayed higher activities than the corresponding neutral PtAm2L2 1:2 Pt:anthraquinone complexes but lower than the neutral diaminedichloro 1:1 complexes. The [Pt(en)LCl]+ complexes were significantly less active than the cis- and trans-[Pt(NH3)2LCl]+ complexes. The cis and trans isomers displayed similar activities. The complexes bearing the shorter linker chains were more active than those with longer chains. In vivo toxicity studies indicate that they are significantly less toxic than cis-DDP.


Advanced Drug Delivery Reviews | 2016

Poly(α-hydroxy acid)s and poly(α-hydroxy acid-co-α-amino acid)s derived from amino acid.

Arijit Basu; Konda Reddy Kunduru; Joshua Katzhendler; Abraham J. Domb

Polyesters derived from the α-hydroxy acids, lactic acid, and glycolic acid, are the most common biodegradable polymers in clinical use. These polymers have been tailored for a range of applications that require a physical material possessing. The physical and mechanical properties of these polymers fit the specific application and also safely biodegrade. These polymers are hydrophobic and do not possess functional side groups. This does not allow hydrophilic or hydrophobic manipulation, conjugation of active agents along the polymer chain, etc. These manipulations have partly been achieved by block copolymerization with, for example, poly(ethylene glycol), to obtain an amphiphilic copolymer. The objective of this review is to survey PLA functional copolymers in which functional α-hydroxy acids derived from amino acids are introduced along the polymer chain, allowing endless manipulation of PLA. Biodegradable functional polyesters are one of the most versatile biomaterials available to biomedical scientists. Amino acids with their variable side chains are ideal candidates for synthesizing such structural as well as stereochemically diverse polymers. They render control over functionalization, conjugation, crosslinking, stimulus responsiveness, and tunable mechanical/thermal properties. Functionalized amino acid derived polyesters are widely used, mainly due to advancement in ring opening polymerization (primarily O-carboxyanhydride mediated). The reaction proceeds under milder conditions and yields high molecular weight polymers. We reviewed on advances in the synthetic methodologies for poly-α-hydroxy esters derived from amino acids with appropriate recent examples.


Biochemical Pharmacology | 1983

The effect of diaminoalkyl-anthraquinone derivatives on the growth of the promastigotes of Leishmania tropica minor, L. T. major, L. donovani and L. aethiopica

Lionel F. Schnur; Uriel Bachrach; Gidon Bar-Ad; Milan Haran; Zev Tashma; Michal Talmi; Joshua Katzhendler

By combining knowledge of polyamine biosynthesis and its inhibition by various analogues with that on the activity of synthetic anthraquinones, a series of six anthraquinone derivatives were synthesized. Their ability to inhibit the growth of leishmanial promastigotes in vitro was used as a preliminary screen to check their potential as new antileishmanial chemotherapeutics. They were tested against four strains, representing four different species; Leishmania tropica major, L. tropica minor, L. aethiopica and L. donovani, associated with four separate disease syndromes. All six derivatives exhibited a fair degree of antileishmanial activity, some being more effective than others. They all inactivated cultures at 100 micrograms/ml and some did so at 10 micrograms/ml and even 1 microgram/ml; but taking different lengths of time to achieve this. Antileishmanial activity associated with anthraquinone derivatives might provide a new approach to the chemotherapy of leishmaniasis.


Macromolecular Bioscience | 2013

Poly(α-hydroxy alkanoic acid)s Derived From α-Amino Acids†

Naomi Cohen-Arazi; Abraham J. Domb; Joshua Katzhendler

Biodegradable polyesters derived from hydrophobic amino acids are synthesized by various techniques, resulting in a wide range of molecular weights. The polymers are prepared via a) direct condensation with p-toluenesulfonic acid (PTSA) as catalyst, b) ring-opening polymerization (ROP) of O-carboxyanhydrides, and c) ROP of cyclic dilactones. The polymers obtained by the first method reach a molecular weight ranging from 1000 to 3000 Da, whereas those formed by the second and third method yield extended molecular weights of 15000-30000 Da. The purity of the monomers as well as their steric bulkiness are key factors affecting the polymerizability of cyclic monomers by ROP. Other parameters such as spatial ring alignment and proximity organization may also play a role.


Hemoglobin | 1988

Detection of Specific Bglobin Mutations in Kurdish Jews with β-Thalassmia

Ariella Oppenheim; Sason Cohen; Ada Goldfarb; Joshua Katzhendler; Joseph Deutsch; Eliezer A. Rachmilewitz

Patients with β-thalassemia, of Kurdish extraction, were screened for the presence of two mutations, in the TATA box and in codon 44, previously discovered in this ethnic isolate. Of the 56 chromosomes analyzed, 13 were found to carry the TATA box mutation and 17 the codon 44 mutation. The result of this work provides a basis for a more efficient prenatal diagnosis program for this community.


Nucleosides, Nucleotides & Nucleic Acids | 1987

An Improved Method for the Preparation of Methyl dichlorophosphite. A Key Reagent In the Phosphite Method of Oligonucleotide Synthesis

Zeev Tashma; I. Ringel; Joseph Deutsch; Sason Cohen; Moshe Weisz; Joshua Katzhendler

Abstract The reaction between phosphorus trichloride (PCl3) and trimethyl phosphite (CH3O)3p, has been examined by 31Pnmr, in order to achieve a simple and efficient procedure for the formation of methyl dichlorophosphite (CH3OPCl2), which is a key intermediate in the synthesis of oligonucleotides. The yield of the reaction was also studied on a preparative scale and it was found that the optimal condition is obtained when the reactants molar ratio is 1:1.


Molecular Biology Reports | 2013

Oleylamine-carbonyl-valinol inhibits auto-phosphorylation activity of native and T315I mutated Bcr-Abl, and exhibits selectivity towards oncogenic Bcr-Abl in SupB15 ALL cell lines

Yousef Najajreh; Hazem Khamaisie; Nili Ruimi; Soliman Khatib; Joshua Katzhendler; Martin Ruthardt; Jamal Mahajna

Chronic myeloid leukemia (CML) is characterized by the presence of p210Bcr-Abl which exhibits an abnormal kinase activity. Selective Abl kinase inhibitors have been successfully established for the treatment of CML. Despite high rates of clinical response, CML patients can develop resistance against these kinase inhibitors mainly due to point mutations within the Abl protein kinase domain. Previously, we have identified oleic acid as the active component in the mushroom Daedalea gibbosa that inhibited the kinase activity of Bcr-Abl. Here, we report that the oleyl amine derivatives, S-1-(1-Hydroxymethyl-2-methyl-propyl)-3-octadec-9-enyl-urea [oleylaminocarbonyl-L-N-valinol,oroleylaminocarbonyl-S-2-isopropyl-N-ethanolamine,oleylamine-carbonyl-L-valinol] (cpd 6) and R-1-(1-Hydroxymethyl-2-methyl-propyl)-3-octadec-9-enyl-urea [oleylamineocarbonyl-D-N-valinol, oleylaminocarbonyl-R-2-isopropyl-N-ethanolamine, or oleylamine-carbonyl-D-valinol] (cpd 7), inhibited the activity of the native and T315I mutated Bcr-Abl. Furthermore, cpd 6 and 7 exhibited higher activity towards the oncogenic Bcr-Abl in comparison to native c-Abl in SupB15 Ph-positive ALL cell line.

Collaboration


Dive into the Joshua Katzhendler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erol Cerasi

Hadassah Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Avner Ramu

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Dan Gibson

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Israel Ringel

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Joseph Deutsch

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Sason Cohen

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Abraham J. Domb

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Eylon Yavin

Hebrew University of Jerusalem

View shared research outputs
Researchain Logo
Decentralizing Knowledge